29/12/2025
香港城市大學 (CityUHK) 數字醫學研究院 (IDM) 自 2024 年 4 月成立以來， 發展迅速！ 在近日舉行的年度大會上，IDM 分享了多項旨在推動數據驅動醫療創新的重大進展：
🔬 關鍵突破：CityUHK–EHP 數據合作實驗室 研究院正式啟動了這個全新的科研平台，讓獲授權的研究人員可以在符合治理與隱私標準下，安全地存取公共醫療系統的匿名化臨床數據。這將大幅加速人工智慧 (AI)、數據分析及數字健康技術的研發，建立更精準的預測模型與個人化護理方案。
🎯 三大核心科研集群：
1️⃣ 生物標記、診斷及治療：致力將實驗室研究轉化為實際的臨床應用方案。
2️⃣ 健康數據及模型：從大規模數據集中提取洞察，支援臨床決策與醫療系統規劃。
3️⃣ 穿戴式裝置、感應器及影像：結合先進感測技術，推動遠端監控與去中心化護理趨勢。
📊 亮眼科研成績：
✅ 目前共有 18 個活躍研究項目 正在進行。
✅ 與全球超過 20 所大學、醫學院及臨床機構 建立合作網絡。
✅ 已舉辦超過 12 場國際研討會，促進全球學術與技術交流。
💡 應對未來挑戰： 面對人口老化與慢性疾病增加的壓力，IDM 透過整合生物醫學、工程學與 AI 技術，致力於實現更主動且精準的醫療服務，為患者及醫療體系帶來長遠效益。
Since its establishment in April 2024, the Institute of Digital Medicine (IDM) at City University of Hong Kong (CityUHK) has achieved remarkable progress in bridging the gap between technology and healthcare. At its recent Annual General Meeting, the IDM showcased how it is transforming the medical landscape through data-driven innovation.
🔬 Key Launch: CityUHK–EHP Data Collaboration Laboratory The IDM has officially launched this new research platform to support the responsible use of health data. It provides authorised researchers with access to anonymised clinical data from the public healthcare system, creating a secure environment to develop advanced Artificial Intelligence (AI), data analytics, and digital health technologies.
🎯 Three Core Research Clusters:
1. Biomarkers, Diagnostics, and Therapeutics: Bridging laboratory research and clinical application.
2. Health Data and Models: Extracting actionable insights from large datasets to support clinical decision-making.
3. Wearables, Sensors, and Imaging: Focusing on remote monitoring and decentralised care to track health continuously.
📊 Global Impact & Collaboration:
• 18 active research projects currently addressing disease detection and treatment.
• Partnerships with over 20 universities, medical schools, and clinical organisations worldwide.
• Organised over 12 symposiums and seminars to foster international knowledge exchange.
💡 The Vision: By integrating engineering, data science, and medical science, the IDM is tackling the pressures of ageing populations and chronic disease burdens. The goal is to move towards more proactive, personalised care that delivers long-term benefits to patients and the healthcare system.
